Jump to main content
Jump to site search

Issue 1, 2017
Previous Article Next Article

AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment

Author affiliations

Abstract

Medullary thyroid cancer (MTC) is often resistant to standard therapies, emphasizing the need for the development of other treatments. A new histone deacetylase inhibitor, AB3, can effectively inhibit MTC cell proliferation in vitro. However, its poor aqueous solubility and stability, fast clearance, and lack of tumor targeting ability limit its in vivo application. Therefore, multifunctional unimolecular micelles were developed for targeted delivery of AB3 for MTC therapy. The unimolecular micelles exhibited a spherical core–shell structure, uniform size distribution, and excellent stability. AB3 was encapsulated into the hydrophobic core of the unimolecular micelles, thus significantly enhancing its aqueous solubility and stability. KE108, a somatostatin analog possessing high affinity to all five subtypes of SSTR, was used as an MTC-targeting ligand. In vitro cellular uptake analyses demonstrated that the KE108 exhibited superior targeting ability in MTC cells compared to octreotide, the first clinically used somatostatin analog. Moreover, the AB3-loaded and KE108-conjugated unimolecular micelles exhibited the best efficacy in suppressing MTC cell growth and tumor marker expression in vitro. Furthermore, AB3-loaded, KE108-conjugated micelles demonstrated the best anticancer efficacy in vivo without any apparent systemic toxicity, thereby offering a promising approach for targeted MTC therapy.

Graphical abstract: AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Sep 2016, accepted on 17 Nov 2016 and first published on 02 Dec 2016


Article type: Paper
DOI: 10.1039/C6TB02530G
Citation: J. Mater. Chem. B, 2017,5, 151-159
  •   Request permissions

    AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment

    R. Jaskula-Sztul, G. Chen, A. Dammalapati, A. Harrison, W. Tang, S. Gong and H. Chen, J. Mater. Chem. B, 2017, 5, 151
    DOI: 10.1039/C6TB02530G

Search articles by author

Spotlight

Advertisements